Cancer Diagnostics – News and Features

News
Decoding the Evolution of Cancer Cells
Researchers at the German Cancer Research Center (DKFZ) have now developed a method that allows for the first time to reconstruct the temporal development—the evolution—of cancerous cells from a single tissue sample.

News
RNA-Based Liquid Biopsy Detects Early Colon Cancer With 95% Accuracy
A study from the University of Chicago introduces an RNA-based liquid biopsy that detects early-stage colorectal cancer with 95% accuracy. The test overcomes the limitations of DNA-based methods.

News
Why Some Prostate Tumors Are Resistant to Treatment
While many patients experience long-term benefits from cancer treatment, some will derive no benefit whatsoever. The study examined RNA sequencing data and clinical outcomes from several prostate cancer clinical trial datasets.

Industry Insight
A New Era Begins for Diagnostic Testing
The diagnostics landscape has transformed over the last 12 months. In this interview, Mara Aspinall, a leader in diagnostic innovation, policy and partner at Illumina Ventures, reflected on the defining moments of the last year and what lies ahead.

News
Bioengineered Tumor Model Aids Fight Against Abdominal Cancer
Researchers have developed a bioengineered hydrogel platform capable of preserving patient-derived tumor tissues for longer periods, a breakthrough that could enhance drug testing for abdominal cancer.

News
Manipulation of Light at the Nanoscale Helps Advance Biosensors
Researchers have developed a new class of nanomaterial that helps to manipulate light and improve the sensitivity of biosensors for detecting disease biomarkers.

News
CIN Signatures Predict Chemotherapy Resistance
A new genomic test has been developed to accurately predict whether a patient’s cancer will resist common chemotherapy treatments.

News
AI Tool Matches Physicians in Mapping Moving Lung Tumors
The tech demonstrated the ability to automate tumor segmentation with high consistency across hospitals and scan types.

Article
The Evolution of Biomarkers in Modern Cancer Care
This article explores how cancer biomarkers improve early detection, guide treatments and predict outcomes to transform personalized cancer care.

News
Ovarian Cancer Risks Linked to Genetic Mutations
Researchers have established a living fallopian tube biobank, utilizing cells and tissues donated by patients, which helps scientists study how ovarian cancer begins — cell by cell — directly in human tissue.
Advertisement